Top compounds associated with response to EML1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.23 2e-08
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 1e-06
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 5e-06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 7e-06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 8e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 1e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA PD318088 CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 7e-05
mRNA PD-0325901 CCLE pan-cancer AAC -0.19 7e-05
Download CSV